The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
The value of the contract is estimated to be between Rs 20-30 crores per year for the next three years
First results demonstrate favourable tolerability of TQL-1055 at all dose levels
The American Association for Clinical Chemistry (AACC); the American Society for Clinical Pathology (ASCP); the American Society of Hematology (ASH); and the International Myeloma Working Group (IMWG), collaborate to develop the guideline
This work has been published in the journal ‘ACS applied materials and interface’
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production
Subscribe To Our Newsletter & Stay Updated
